drugset / Trial / NCT01526278
Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate clinical safety and pharmacokinetics of Maxmarvil® in healthy postmenopausal women
Timeline
- Start
- 2011-10
- Primary completion
- 2012-07
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | 5 mg | Oral |
| Subject | Calcitriol | Small molecule | 0.5 ug | Oral |